Engineers Gate Manager LP Sutro Biopharma, Inc. Transaction History

Engineers Gate Manager LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $87,167 - $159,111	-29,852 Reduced 37.05%	50,718 $148,000
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $78,447 - $135,543	23,990 Added 42.4%	80,570 $455,000
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $117,120 - $256,873	56,580 New	56,580 $242,000
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $22,055 - $41,599	-4,923 Reduced 21.15%	18,355 $84,000
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $18,870 - $28,183	3,488 Added 17.63%	23,278 $188,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $102,314 - $140,706	19,790 New	19,790 $110,000
Q2 2022 Aug 15, 2022	SELL	$3.41 - $8.95 $47,058 - $123,509	-13,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $107,364 - $211,278	13,800 New	13,800 $113,000
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $244,760 - $324,510	-14,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $261,435 - $345,390	14,500 New	14,500 $270,000
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $395,370 - $536,644	-19,486 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $197,977 - $467,274	19,486 New	19,486 $423,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.